Company Filing History:
Years Active: 2023
Title: Innovator Spotlight: Silpa Suthram
Introduction
Silpa Suthram is a prominent inventor based in San Jose, California. She has made significant contributions to the field of oncology with her innovative research and patent. With a focus on the therapeutic methods targeting Epstein Barr virus (EBV) positive cancers, Suthram represents the forefront of cancer treatment innovations.
Latest Patents
Suthram holds a notable patent related to anticancer agents. This patent discloses therapeutic methods for administering compounds that modulate the C-C chemokine receptor type 4 (CCR4), aimed specifically at treating malignancies associated with EBV. This invention underscores her commitment to developing targeted therapies that could revolutionize the treatment landscape for cancer patients.
Career Highlights
Silpa currently works at Rapt Therapeutics, Inc., a company known for its emphasis on pioneering new therapies for cancer patients. Throughout her career, she has demonstrated a deep dedication to medical research, focusing on the intersection of immunology and oncology.
Collaborations
In her role at Rapt Therapeutics, Suthram collaborates with esteemed colleagues, including Gene Cutler and William Yew-Wai Ho. These collaborations enable a multifaceted approach to research and development, enhancing the potential for breakthroughs in cancer treatment.
Conclusion
Silpa Suthram stands out as an innovator in her field, with her work continuing to push the boundaries of cancer research. Her patent and collaborative efforts demonstrate her significant impact on healthcare and underscore the importance of innovation in the fight against cancer.